Lina Concierge Med Spa advertises compounded semaglutide, tirzepatide and microdosing through telehealth. Its homepage emphasizes a founder-led concierge model with access across all 50 states, while leaving the individual price to consultation. The public cancellation statements and clinical-evidence presentation require closer scrutiny.

We checked the homepage, semaglutide page and terms on October 15, 2026. We did not consult with the practice, verify state-by-state coverage or validate its projected outcomes. This field note assesses published information, not personal care experience or the quality of a dispensed product.

The quick read

  • Pricing is confirmed at consultation; no complete numeric GLP-1 tariff was established.
  • The treatment FAQ says 30 days’ cancellation notice; terms describe 48 hours before auto-refill.
  • The homepage’s clinical trajectory is not independently established evidence for the actual compounded formulations.

A concierge description still needs named responsibilities

The homepage identifies founder Melissa Linares, NP, and describes care delivered by independent licensed providers. It advertises secure telehealth in all 50 states. We did not verify an individual clinician’s authorization or treatment availability in every state. Ask who evaluates the intake, who prescribes and which team responds to clinical questions.

Obtain the complete consultation quote

The site describes pricing as confirmed during consultation. The semaglutide page describes a flat-rate program with compounded medication, check-ins, provider-directed adjustments and delivery. We did not establish a numeric price, payment term or exact pharmacy assignment. Request an itemized agreement showing the amount due, renewal interval, medicine supply and any separate laboratory or visit charges.

The two cancellation deadlines are not interchangeable

The treatment FAQ says memberships may be canceled with 30 days’ notice before the next billing cycle. The terms describe disabling subscription auto-refill at least 48 hours before monthly processing, with recurring charges every 30 days. It is unclear from those pages whether they govern different purchases. Obtain the actual rule for your plan in writing rather than assuming the shorter notice applies.

Prescription refunds have additional conditions

The terms allow an initial cancellation request within 24 hours only if the provider network has not received the order. They list limited refund circumstances including an unshipped order, a declined prescription, damage or the wrong medicine. The treatment FAQ separately describes services and processed prescriptions as nonrefundable. Stopping renewal and requesting an existing-order refund are distinct actions; neither should be inferred from the concierge branding.

The outcomes chart needs evidence for its actual claim

The homepage displays a projected clinical trajectory and attributes it to trials of compounded semaglutide and tirzepatide. We did not identify trial evidence in the checked materials establishing that trajectory for the specific formulations dispensed through Lina. FDA explains that compounded products are not FDA approved or reviewed for safety, effectiveness and quality before marketing. We do not reproduce the chart as a likely personal result.

Our assessment: the consultation must resolve material gaps

Lina describes ongoing access and a coordinated clinical relationship, but we did not test responsiveness or continuity. The deciding information is the actual quote, prescriber, pharmacy and consistent cancellation policy. The terms identify Melissa Caramanica Nurse Practitioner in Acute Care PLLC; confirm the entity on the purchase agreement. Use the provider-check guide to verify responsibilities and records access before committing to an unpriced program.

Sources & reading notes

Public materials checked October 15, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. Lina: programs and practice
  2. Lina: semaglutide program
  3. Lina: terms
  4. FDA: unapproved GLP-1 drugs

How we research · How commercial placement works